These studies agree that some liver tests may be altered in severe COVID-19 cases, including those that estimate biosynthetic function (ALB; prothrombin time), hepatic clearance/biliary secretion capacity (BIL: bilirubin), and other markers of liver or biliary injury (GGT: gamma-glutamyltransferase; ALP: alkaline phosphatase). Here, ALB is linked to COVID-19.